The once-loved stock is on pace for its third worst session since 1972.
We’re downgrading Lilly and asking ourselves tough questions after its obesity pill letdown
About the author
BREAKING NEWS
- Carville apologizes, pulls YouTube video after letter from Melania Trump’s lawyer
- DOE Approves Fifth Loan Disbursement to Restart the Palisades Nuclear Plant
- What’s at stake for oil prices ahead of Trump’s Friday deadline for Russia-Ukraine cease-fire
- ‘I feel shaken’: A man offered to powerwash my patio for $50. He would not take no for an answer.
- US Air Force to deny retirement pay to transgender service members being separated from the service
- This semiconductor play with a solid dividend ‘gets no respect’ but could be due for upside
